US 12036243
BCMA CAR-T cells with enhanced activities
granted A61KA61K2239/31A61K2239/38
Quick answer
US patent 12036243 (BCMA CAR-T cells with enhanced activities) held by Allogene Therapeutics, Inc. expires Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Allogene Therapeutics, Inc.
- Grant date
- Tue Jul 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 32
- CPC classes
- A61K, A61K2239/31, A61K2239/38, A61K2239/48, A61K38/00